Understanding and meeting injection device needs in multiple sclerosis: a survey of patient attitudes and practices
Author(s) -
Verdun di Cantogno,
David Russell,
Tom Snow
Publication year - 2011
Publication title -
patient preference and adherence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.885
H-Index - 48
ISSN - 1177-889X
DOI - 10.2147/ppa.s14903
Subject(s) - medicine , glatiramer acetate , multiple sclerosis , dosing , vial , intramuscular injection , health professionals , health care , intensive care medicine , psychiatry , chemistry , economics , economic growth
All established disease-modifying drugs for multiple sclerosis require parenteral administration, which can cause difficulties for some patients, sometimes leading to suboptimal adherence. A new electronic autoinjection device has been designed to address these issues.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom